Results
|
|
661.
|
|
|
|
662.
|
|
|
|
663.
|
|
|
|
664.
|
|
|
|
665.
|
|
|
|
666.
|
|
|
|
667.
|
|
|
|
668.
|
|
|
|
669.
|
|
|
|
670.
|
|
|
|
671.
|
|
|
|
672.
|
|
|
|
673.
|
|
|
|
674.
|
|
|
|
675.
|
Regulatory and Health Technology Assessment Considerations for Disease-Modifying Drugs in Alzheimer's Disease. [electronic resource] by
- Bouvy, Jacoline C
- Jonsson, Pall
- O'Rourke, Diana
- Chadha, Antonella Santuccione
- Hedberg, Niklas
- Makady, Amr
- Xoxi, Entela
- Wied, Christine Gispen-de
- Schiel, Anja
- Long, Raj
- Gallacher, John
Producer: 20191014
In:
CNS drugs vol. 32
Availability: No items available.
|
|
|
676.
|
|
|
|
677.
|
|
|
|
678.
|
|
|
|
679.
|
|
|
|
680.
|
|